Replies to post #117676 on Biotech Values

[mcbio]

No discussion of the HCV arena would be complete without Bavituximab, so here is PPHM’s latest PR:

finance.yahoo.com/news/Peregrine-Presents-Phase-Ib-iw-304801467.html?x=0&.v=1

(The above is facetious, of course.)

LOL I assume you meant to refer to both the HCV and HIV arenas. ; )